🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

Todos Aviação Tecnologia Aviação Executiva Negócios Desenvolvimento Web Empreendedorismo Comunidade Empresas Dicas ESG Caso de Sucesso Esportes Notícias Inteligência Artificial Eventos Investimentos IoT Marketing Meio Ambiente Sistemas ERP
340 notícias encontradas para "treat"
Scientists discover why peach fuzz can suddenly make you itch
Scientists discover why peach fuzz can suddenly make you itch
A newly discovered network of fine hairs and specialized nerve cells appears to form a dedicated system for sensing mechanical itch, offering fresh insight into why chronic itching occurs. Because humans show signs of having the same pathway, the research could pave the way for m
Admin Recifes 15/07/2026 2
Foto: Ben Leonard / Pexels
Negócios
Passenger 'nearly sucked out of window mid-air' on Ryanair plane
Ryanair confirm a passenger was given medical treatment after an incident on a Malta Air flight, which is owned by Ryanair.
Admin Recifes 10/07/2026 7
Foto: Worldspectrum / Pexels
Dicas
The Guardian view on Nigel Farage’s crypto cash: accountability is not a conspiracy | Editorial
Reform UK presents itself as the people’s voice while opaque digital wealth flows around it. That makes transparency a democratic necessityTwice now, the Guardian’s questions about Reform UK’s finances appear to have been pre-empted by stories friendly to the party. This paper revealed in April that Nigel Farage received £5m from the crypto billionaire Christopher Harborne – but an interview with Reform UK’s leader, claiming he needed the cash “for security”, was published hours earlie
Admin Recifes 09/07/2026 8
Foto: Mitchell Henderson / Pexels
Dicas
UK housing market downturn eases but sentiment remains ‘fragile’, surveyors say – business live
Brent crude dips slightly below $78 a barrel; most Asian stock markets bounce backBritain’s second-biggest drugmaker GSK has also taken a hit from recent drug failures.The Californian biotech Alector has said that GSK has ended their neuroscience collaboration covering ​two experimental antibody drugs, after both drug candidates suffered setbacks in clinical trials.The CARDIO-TTRansform trial was designed to examine the role of Wainua, a gene silencer treatment, on top of today’s stand
Admin Recifes 09/07/2026 8
← Anterior 1 … 28 29